Table 1 Verified genes/proteins based on the TCGA/HPA and iProX databases in lung, liver, kidney and thyroid
From: The putative mechanistic insights on how SARS-CoV-2 might influence the outcomes in cancer patients
Tissues | Shared genes/proteins | Reminding genes/proteins | ||
|---|---|---|---|---|
Changes showing poor effects | Changes showing non-poor effects | Changes showing poor effects | Changes showing non-poor effects | |
Lung | KRT6A, STEAP1, SLC7A5 | SLC2A1 | C1QBP, C5AR1, CALU, CKS2, CNPY2, COX5A, CTSB, CTSL, FKBP10, GFPT2, IRAK2, KRT17, METTL7B, MMP14, MRPL42, MTHFD2, NNMT, OAT, PFN2, PLIN2, PTX3, RCN1, S100P, SERPINE1, TNC, TREM1, YBX1, CTSA, FOSL2, IMP4, KRT14, LOXL1, PRDX3, PRDX4, SAA1, SCD, SFN, SOD2, CAVIN1, TMEM100, SELENBP1 | PRDX2, SERPINB9, ALPL, FGA, GABARAPL1, RNF13, GLUL |
Liver | S100P, SRXN1, RGN, PBLD, NDRG2, XDH, PDK4, TOP2A | Â | BCL3, CD151, CD9, CHI3L1, FKBP5, FLOT2, GOLM1, GPX2, HK2, HRNR, IMPDH2, PFKFB3, PTGS2, RBM3, SERPINA3, SERPINE1, SPINK1, TSPAN8, TUFT1, BNIP3L, SDC4, THBS1, TSPAN31, ACY1, CA2, DPYSL3, GSTA1, PGM1, APOM, SEC14L2, CLEC4M | AHR, KAT7, MRC2, NUPR1, PGLS, POSTN, GALK1, GALNT2, NOLC1, SLFN11, B4GALT1 |
Kidney | NNMT, TGM2, ACY1, HAO2, PCK2, FBP1 | Â | ADAMTS1, CD151, HIF1A, JUNB, SAA1, SPP1, SOX9, NR4A1, NAMPT, DNPH1 | SLC39A1, SPARCL1, TIMP3, ARG2 |
Thyroid | Â | Â | ALOX5, AXL, CXCL12, FKBP5, SLC34A2, STC1, FBN1, NRP2, HBB | APOA1 |